Wendy Sonnet
Clinical Operations Manager at InhaTarget Therapeutics | Genappe, Walloon Region, Belgium
Wendy Sonnet’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Clinical Operations Manager at InhaTarget Therapeutics in December 2021 - Present
Regulatory Affairs Manager at BONE THERAPEUTICS S.A. in February 2021 - December 2021
Clinical Operations Manager at BONE THERAPEUTICS S.A. in February 2016 - January 2021
Université catholique de Louvain, PhD in Sciences, January 2007 to January 2012
Université catholique de Louvain, Master's degree, January 2003 to January 2007
Université Laval, International exchange (4 months), January 2006
InhaTarget Therapeutics develops innovative and targeted dry powders for inhalation (“DPI”) that aim to improve the treatmentsof respiratory diseases, with a particular focus on lung cancer Capitalizing on its advanced expertise in pulmonary drug delivery (especially in DPI), InhaTarget Therapeutics organizes its activities under two strands: 1. The early development of proprietary products (phase I/II) to be licensed to pharmaceutical partners. InhaTarget therapeutics wants to focus on its core competencies (R&D and clinical proof-of concept) to deliver proven high-quality products to a pharma partner which will be in charge of the conduct of later clinical studies, regulatory approvals and marketing and sales. Aware of the challenging specificities of the production processes and equipment for high potency compounds, InhaTarget therapeutics may take care of the GMP production of the DPI products (both the samples for clinical trials and the commercial products). 2. The custom development requested by pharmaceutical companies of innovative products for inhalation in different indications (infections, asthma, COPD, etc.), from the pre-formulation to the clinical proof-of-concept. Using the keen expertise of the team and its specialized equipment, InhaTarget Therapeutics develops, in collaboration with interested pharma partners, innovative DPIs. It does so using particle engineering techniques that are scalable, such as high-pressure homogenization and spray-drying and that, preferably, use approved, endogenous or well-tolerated excipients. The services of InhaTarget therapeutics on lung drug delivery range from in vitro evaluation, to the evaluation of new excipients and/or devices, particle engineering and production methods using novel processes and aerosol formulations, and finally to preclinical studies in different animal models, in vivo evaluation of lung deposition in humans, local and systemic drug bioavailability, and clinical outcomes.
Discover more about InhaTarget TherapeuticsCEO Genflow Biosciences
Non Executive Director at InhaTarget Therapeutics
(Aug 2020 – Present)
R&D Formulation Lead, PhD, PharmD.
R&D Formulation Lead at InhaTarget Therapeutics
(Jan 2026 – Present)
Technicien analytique chez InhaTarget Therapeutics
Technicien analytique at InhaTarget Therapeutics
(Oct 2021 – Present)
M.Sc. Student in Biotechnology (ESBS) & Chemical Engineering (ECPM) | Driven to contribute to innovative Medical Research
In Vitro Scientist Intern | Innovative Inhalation Therapeutics for Lung Diseases at InhaTarget Therapeutics
(Apr 2026 – Present)
Non-Clinical Operations Lead at Inhatarget Therapeutics
Non-Clinical Operations Lead at InhaTarget Therapeutics
(Mar 2025 – Present)
Co-founder & CEO at InhaTarget Therapeutics
Co-founder & CEO at InhaTarget Therapeutics
(Aug 2019 – Present)
What is Wendy Sonnet email address?
Email Wendy Sonnet at [email protected]. This email is the most updated Wendy Sonnet's email found in 2026.
How to contact Wendy Sonnet?
To contact Wendy Sonnet send an email to [email protected].
What company does Wendy Sonnet work for?
Wendy Sonnet works for InhaTarget Therapeutics.
What is Wendy Sonnet's role at InhaTarget Therapeutics?
Wendy Sonnet is Clinical Operations Manager
What industry does Wendy Sonnet work in?
Wendy Sonnet works in the Pharmaceuticals industry.